Bank Of America Corp Neurocrine Biosciences Inc Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Bank Of America Corp holds 623,588 shares of NBIX stock, worth $85.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

623,588

Previous 618,931 0.75%

Holding current value

$85.5 Million

Previous $85.2 Million 15.74%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $533,599 - $713,219	4,657 Added 0.75%	623,588 $71.8 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $6.83 Million - $7.48 Million	52,218 Added 9.21%	618,931 $85.2 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $12.2 Million - $13.5 Million	93,734 Added 19.82%	566,713 $78.2 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $716,927 - $897,324	-6,759 Reduced 1.41%	472,979 $62.3 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $6.25 Million - $7.32 Million	-69,757 Reduced 12.69%	479,738 $45.2 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $4.69 Million - $6.13 Million	-49,851 Reduced 8.32%	549,495 $55.6 Million
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $11.9 Million - $14.1 Million	-111,085 Reduced 15.64%	599,346 $71.6 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $11.6 Million - $13.6 Million	126,109 Added 21.58%	710,431 $75.5 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $870,523 - $1.15 Million	-11,486 Reduced 1.93%	584,322 $57 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $6.5 Million - $8.51 Million	89,721 Added 17.73%	595,808 $55.9 Million
Q4 2021 Feb 08, 2022	SELL	$79.65 - $106.22 $6.73 Million - $8.97 Million	-84,478 Reduced 14.3%	506,087 $43.1 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $885,758 - $1.02 Million	10,278 Added 1.77%	590,565 $56.6 Million
Q2 2021 Sep 13, 2021	BUY	$89.43 - $102.27 $51.9 Million - $59.3 Million	580,287 New	580,287 $56.5 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Neurocrine Biosciences Inc Transaction History